CPHI vs NDSN · rev $4.1M vs P/E 31, rev $2.69B
China Pharma Holdings Inc (CPHI) versus Nordson Corporation (NDSN) — a side-by-side from cached financials, not a winner call.
China Pharma Holdings Inc (CPHI) is a drug manufacturers - specialty & generic company listed on US.
Nordson Corporation (NDSN) is a specialty industrial machinery company listed on NASDAQ.
Latest reported CPHI revenue for 2025-12-31 was $4.1M. Net income was -$3.2M. Revenue was down 8.5% from 2024-12-31 to 2025-12-31. CPHI currently screens at market cap $29.0M.
Latest reported NDSN revenue for 2024-10-31 was $2.69B. Net income was $467.3M. Revenue was up 2.3% from 2023-10-31 to 2024-10-31. NDSN currently screens at market cap $16.17B and trailing P/E 31.0.
CPHI currently screens at market cap $29.0M. NDSN currently screens at market cap $16.17B and trailing P/E 31.0.
Not investment advice. Open the CPHI and NDSN stock pages for the full models.
Not investment advice.